Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Euryarchaeota, a phylum of archaea, has been implicated in the modulation of gut microbiota in patients with non-alcoholic fatty liver disease (NAFLD).
A study suggests that the abundance of Euryarchaeota may be altered in patients with Non-Alcoholic Fatty Liver Disease (NAFLD), and its modulation could potentially impact the progression of the disease
The gut microbiota, including Euryarchaeota, is increasingly recognized as a potential factor in the development and progression of Non-Alcoholic Fatty Liver Disease (NAFLD). However, the specific role of Euryarchaeota in the pathogenesis of NAFLD and its potential as a targ…